Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains (variable regions or complementarity-determining region surfaces) capable of binding two different antigens or two different epitopes of the same antigen.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
報告